| Vitamin D and Alzheimer’s disease: neurocognition to therapeutics A Banerjee, VK Khemka, A Ganguly, D Roy, U Ganguly, S Chakrabarti International Journal of Alzheimer’s Disease 2015, 2015 | 134 | 2015 |
| Alpha-synuclein as a biomarker of Parkinson’s disease: good, but not good enough U Ganguly, S Singh, S Pal, S Prasad, BK Agrawal, RV Saini, ... Frontiers in aging neuroscience 13, 702639, 2021 | 76 | 2021 |
| Oxidative stress, neuroinflammation, and NADPH oxidase: implications in the pathogenesis and treatment of Alzheimer’s disease U Ganguly, U Kaur, SS Chakrabarti, P Sharma, BK Agrawal, L Saso, ... Oxidative Medicine and Cellular Longevity 2021, 1-19, 2021 | 66 | 2021 |
| COVID-19 in India: are biological and environmental factors helping to stem the incidence and severity? SS Chakrabarti, U Kaur, A Banerjee, U Ganguly, T Banerjee, S Saha, ... Aging and disease 11 (3), 480, 2020 | 58 | 2020 |
| Alpha-synuclein, proteotoxicity and Parkinson's disease: search for neuroprotective therapy U Ganguly, SS Chakrabarti, U Kaur, A Mukherjee, S Chakrabarti Current neuropharmacology 16 (7), 1086-1097, 2018 | 58 | 2018 |
| Meningoencephalitis associated with COVID-19: a systematic review R Mondal, U Ganguly, S Deb, G Shome, S Pramanik, D Bandyopadhyay, ... Journal of neurovirology 27, 12-25, 2021 | 42 | 2021 |
| COVID-19 and emerging spinal cord complications: a systematic review R Mondal, S Deb, G Shome, U Ganguly, D Lahiri, J Benito-León Multiple sclerosis and related disorders 51, 102917, 2021 | 38 | 2021 |
| Interaction of α-synuclein and Parkin in iron toxicity on SH-SY5Y cells: implications in the pathogenesis of Parkinson's disease U Ganguly, A Banerjee, SS Chakrabarti, U Kaur, O Sen, R Cappai, ... Biochemical Journal 477 (6), 1109-1122, 2020 | 32 | 2020 |
| Is 1, 8-cineole-rich extract of small cardamom seeds more effective in preventing Alzheimer’s disease than 1, 8-cineole alone? K Paul, U Ganguly, S Chakrabarti, P Bhattacharjee Neuromolecular Medicine 22, 150-158, 2020 | 24 | 2020 |
| Dopamine cytotoxicity on SH-SY5Y cells: Involvement of α-synuclein and relevance in the neurodegeneration of sporadic Parkinson’s disease U Ganguly, A Ganguly, O Sen, G Ganguly, R Cappai, A Sahoo, ... Neurotoxicity research 35, 898-907, 2019 | 21 | 2019 |
| Visual contrast sensitivity could be an early marker of diabetic retinopathy S Pramanik, S Chowdhury, U Ganguly, A Banerjee, B Bhattacharya, ... Heliyon 6 (10), 2020 | 20 | 2020 |
| Vitamin D and immuno-pathology of COVID-19: many interactions but uncertain therapeutic benefits A Banerjee, U Ganguly, S Saha, S Chakrabarti, RV Saini, RK Rawal, ... Expert review of anti-infective therapy 19 (10), 1245-1258, 2021 | 19 | 2021 |
| Protective effects of cyclosporine A on neurodegeneration and motor impairment in rotenone-induced experimental models of Parkinson's disease S Singh, U Ganguly, S Pal, G Chandan, R Thakur, RV Saini, ... European Journal of Pharmacology 929, 175129, 2022 | 9 | 2022 |
| Efficacy and cost-effectiveness of anti-VEGF for treating diabetic retinopathy in the Indian population S Pramanik, LK Mondal, SK Paine, S Jain, S Chowdhury, U Ganguly, ... Clinical Ophthalmology, 3341-3350, 2021 | 6 | 2021 |
| Spectrum of spinal cord involvement in COVID-19: A systematic review R Mondal, S Deb, G Shome, U Ganguly, D Lahiri, JB Leon medRxiv, 2020.09. 29.20203554, 2020 | 6 | 2020 |
| Cross‐immunity and trained immunity in explaining variable COVID‐19 mortality—Guidance for future pandemics S Chakrabarti, SS Chakrabarti, U Kaur, BK Agrawal, U Ganguly, K Jin Journal of Medical Virology 93 (7), 4094, 2021 | 4 | 2021 |
| Decreased glucose-6-phosphate dehydrogenase activity along with oxidative stress affects visual contrast sensitivity in alcoholics S Pramanik, U Ganguly, VK Khemka, A Banerjee Alcohol 73, 17-24, 2018 | 4 | 2018 |
| Effects of the SARS-CoV-2 Spike protein on in vitro aggregation of alpha synuclein-probable molecular interactions and clinical implications SS Chakrabarti, S Gupta, U Ganguly, A Kaushal, AK Yadav, U Kaur, ... Qeios. doi 10, 2022 | 3 | 2022 |
| Immunotherapeutic interventions in Parkinson's disease: Focus on α-Synuclein U Ganguly, S Singh, S Chakrabarti, AK Saini, RV Saini Advances in Protein Chemistry and Structural Biology 129, 381-433, 2022 | 3 | 2022 |
| GLUT inhibitor WZB117 induces cytotoxicity with increased production of amyloid-beta peptide in SH-SY5Y cells preventable by beta-hydroxybutyrate: implications in Alzheimer’s … G Chandan, U Ganguly, S Pal, S Singh, RV Saini, SS Chakrabarti, ... Pharmacological Reports 75 (2), 482-489, 2023 | 2 | 2023 |
SASANKA CHAKRABARTIM M Institute of Medical Sciences and Research,MMDU, Mullana, HaryanaVerified email at mmumullana.org
